Table 1 Relationship between p-ERK expression and clinicopathological parameters in 90 gastric adenocarcinoma cases.
Characteristic | Number of cases number(%) | p-ERK expression:number(%) | P value | |
|---|---|---|---|---|
Low | High | |||
Total | 90 | 48(53.3) | 42(46.7) | |
Average years | 62.1 ± 12.3 | 61.6 ± 11.5 | 62.5 ± 13.4 | 0.66 |
< 65 | 52(57.8) | 30(62.5) | 22(52.4) | 0.332 |
≥ 65 | 38(42.3) | 18(37.5) | 20(47.6) | |
Gender | ||||
Male | 53(58.9) | 30(62.5) | 23(54.8) | 0.457 |
Female | 37(41.1) | 18(37.5) | 19(45.2) | |
TNM stage | ||||
I-II | 36(40) | 24(50.0) | 12(28.6) | 0.038 |
III- IV | 54(60) | 24(50.0) | 30(71.4) | |
Tumor size (cm) | 5.7 ± 2.7 | 5.3 ± 2.3 | 6.2 ± 2.9 | 0.093 |
< 5 cm | 35(38.9) | 20(41.7) | 15(35.7) | 0.563 |
≥ 5 cm | 55(61.1) | 28(58.3) | 27(64.3) | |
Lymphovascular Invasion | 25(27.8) | 9(18.8) | 16(38.1) | 0.041 |
Distant metastasis | 4(4.4) | 3(6.3) | 1(2.4) | 0.374 |
